InvestorsHub Logo
Followers 27
Posts 744
Boards Moderated 0
Alias Born 07/12/2012

Re: asmarterwookie post# 113991

Tuesday, 02/26/2013 3:14:02 PM

Tuesday, February 26, 2013 3:14:02 PM

Post# of 345990
Wook, I'm in your CALM party, too.

Bavi will soon enough be recognized by the larger investment world, JUST AS SOON as the Big Boys, MM's, and Hedgies get their piece of the action with these low prices.

Lots of good posts today on why a little bitty penny stock is getting so many people "hot and bothered." Gee, a $1.30 stock from Tustin, CA. Quick! Run the presses! The stock is down $0.15 today! Time to baiiiillllll....

And yet no news.

My personal take on Bavi relates to the work of a German physician (oncologist) named Hans Nieper. (Google him.) He cured Reagan's colon cancer. He was a world-renowned oncologist. When the rich, famous, and influential got cancer, they didn't call for chemotherapy and radiation, they called for Hans Nieper, MD.

Nieper argued that the best way to fight cancer is to strengthen the immune system, not weaken it. He was particularly interested in the electro-magnetic potential of the cell membrane and how depolarization changes in that membrane, when affected by cancer, placed the cell OUTSIDE THE GRASP OF THE IMMUNE SYSTEM.

Nieper argued that in order to render the cancerous cell once again susceptible to the immune system, the depolarized cell had to once again be repolarized.

What's critical to us is that phosphatidyserine, when extroverted by flippase to the outer cell membrane DEPOLARIZES the cancer-affected cell, thus placing it beyond the grasp of the immune system.

Enter Bavi. Tie up the extroverted PS, regenerate a potential in the outer cell membrane, and voila, the immune system is back in business and goes back to attacking the cancer.

Some fascinating DD to look over if interested.

Of course, all this is IMHO. But I did add another 5K to my stash today. Take that for what it's worth.

GLTAL

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News